5/7/2015 1:25:13 PM - Holding its ground after the 5/04/15 mid-day report last cautioned members - "No resistance remains due to overhead supply after a considerable gap up and volume-driven gains last week for new 52-week highs. Fundamental concerns remain. Reported earnings +4% on +21% sales revenues for the Dec '14 quarter, and prior comparisons were below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines."
5/4/2015 12:59:46 PM - No resistance remains due to overhead supply after a considerable gap up and volume-driven gains last week for new 52-week highs. Fundamental concerns remain. Reported earnings +4% on +21% sales revenues for the Dec '14 quarter, and prior comparisons were below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines.
2/23/2015 12:56:56 PM - No resistance remains due to overhead supply and held its ground stubbornly near its 52-week high since noted in prior mid-day reports with caution - "Reported earnings +15% on +18% sales revenues for the Dec '14 quarter, marking its 3rd straight comparison below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines."
2/13/2015 1:08:12 PM - Reported earnings +15% on +18% sales revenues for the Dec '14 quarter, marking its 3rd straight comparison below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines. No resistance remains due to overhead supply and it is hitting a new 52-week high today. Held its ground stubbornly following recent volume-driven gains. Went through a long consolidation since noted with caution in the 3/13/14 mid-day report.
2/5/2015 12:55:33 PM - No resistance remains due to overhead supply and it is perched at its high, holding its ground stubbornly following recent volume-driven gains. The 2/02/15 mid-day report cautioned members - "Went through a long consolidation since noted with caution in the 3/13/14 mid-day report. Reported earnings +15% on +18% sales revenues for the Dec '14 quarter, marking its 3rd straight comparison below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines."
2/2/2015 1:10:13 PM - No resistance remains due to overhead supply and it is perched at its high following recent volume-driven gains. Went through a long consolidation since noted with caution in the 3/13/14 mid-day report. Reported earnings +15% on +18% sales revenues for the Dec '14 quarter, marking its 3rd straight comparison below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines.
1/30/2015 1:10:07 PM - No resistance remains due to overhead supply and it touched a new high today following a long consolidation since last noted with caution in the 3/13/14 mid-day report. Reported earnings +15% on +18% sales revenues for the Dec '14 quarter, marking its 3rd straight comparison below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines.
3/13/2014 12:47:06 PM - Making its 2nd consecutive mid-day report appearance. No resistance remains due to overhead supply, however it has not formed a sound base pattern. Made limited headway after clearing the previously noted sound base pattern, then undercut its 50 DMA line and rebounded with volume-driven gains this week. Reported earnings +39% on +25% sales revenues for the Dec '13 quarter, marking its 3rd comparison above the +25% minimum guideline (C criteria). This helps the Chinese Medical/Dental Services firm's earnings history better match the fact-based investment system's guidelines.
3/12/2014 12:42:01 PM - Made limited headway after clearing the previously noted sound base pattern then undercut its 50 DMA line and rebounded with volume-driven gains this week. Reported earnings +39% on +25% sales revenues for the Dec '13 quarter, marking its 3rd comparison above the +25% minimum guideline. The 2/25/14 mid-day report cautioned members - "No resistance remains due to overhead supply. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
2/25/2014 12:32:16 PM - Perched at its 52-week high after clearing the previously noted sound base pattern with its 5th consecutive gain marked by increasing volume. The 2/24/14 mid-day report cautioned members - "No resistance remains due to overhead supply. Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
2/24/2014 12:45:50 PM - Gapped up today hitting a new 52-week high, clearing a sound base pattern with its 5th consecutive gain marked by increasing volume. No resistance remains due to overhead supply. Prior mid-day reports cautioned members - "Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
12/26/2013 1:09:03 PM - Perched at its 52-week high today after 6 consecutive gains marked by volume. No resistance remains due to overhead supply, but it is extended from any sound base pattern. Prior mid-day reports cautioned members - "Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
12/24/2013 11:32:36 AM - Powering to another new 52-week high with today's 6th consecutive gain. No resistance remains due to overhead supply, but it is extended from any sound base pattern. Prior mid-day reports cautioned members - "Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
12/23/2013 1:05:59 PM - Powering to a new 52-week high with today's 5th consecutive gain. No resistance remains due to overhead supply, and it is extended from any sound base pattern. The 11/20/13 mid-day report last cautioned members - "Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
11/20/2013 1:07:04 PM - Perched near its 52-week high today and no resistance remains due to overhead supply, but it is extended from any sound base pattern. The 11/14/13 mid-day report cautioned members - "Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
11/14/2013 1:06:32 PM - Perched at its 52-week high today and no resistance remains due to overhead supply, but it is extended from any sound base pattern. Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria).
11/13/2013 1:04:06 PM - Perched at its 52-week high after a volume-driven gain on the prior session. No resistance remains due to overhead supply. Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria).
10/30/2013 1:57:56 PM - Churning above average volume while recently hovering in a tight range near its 52-week high after an impressive streak of weekly gains. No resistance remains due to overhead supply. Prior mid-day reports cautioned members - "Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
10/16/2013 1:24:59 PM - Churning above average volume while hovering near its 52-week high today, encountering distributional pressure. Tallied 11 weekly gains in the span of 12 prior weeks. Technically, no resistance remains due to overhead supply but it is extended from any sound base. The 10/14/13 mid-day report cautioned members - "Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria)."
10/14/2013 1:11:12 PM - Retreating from its 52-week high today following 2 consecutive volume-driven gains. Tallied 11 weekly gains in the span of 12 prior weeks. Technically, no resistance remains due to overhead supply. Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria).
10/11/2013 1:00:16 PM - Challenging its 52-week high with today's 2nd consecutive volume-driven gain. Tallied 10 weekly gains in the span of 11 prior weeks. Technically, no resistance remains due to overhead supply. Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria).
10/10/2013 12:38:09 PM - This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria). Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. Challenging its 52-week high with today's volume-driven gain. Tallied 10 weekly gains in the span of 11 weeks. Technically, no resistance remains due to overhead supply.
10/9/2013 12:59:30 PM - This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria). Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. Pulling back from its 52-week high with today's 3rd consecutive volume-driven loss after a spurt of 10 weekly gains in the span of 11 weeks. Technically, no resistance remains due to overhead supply.
10/7/2013 12:47:20 PM - This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria). Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. Perched at its 52-week high today after a spurt of 10 weekly gains in the span of 11 weeks. Technically, no resistance remains due to overhead supply.
9/24/2013 1:16:57 PM - Reported earnings +39% on +9% sales revenues for the Jun '13 quarter but fundamental concerns remain. Hit a new 52-week high on the prior session and it is on track for its 9th weekly gain in the span of 10 weeks. Technically, no resistance remains due to overhead supply. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria).
9/3/2013 12:44:56 PM - Encountering mild distributional pressure since last noted in the 8/23/13 mid-day report with caution - "Fundamental concerns remain however, technically, no resistance remains due to overhead supply. This Chinese Medical/Dental Services firm hit is perched at its 52-week high following 3 consecutive gains. Earnings history is not a match with the fact-based investment system's guidelines, however the Jun '13 quarterly comparison showed an earnings increase of +39%, above the +25% guideline (C criteria) on +9% sales revenues. "
8/23/2013 12:41:57 PM - Fundamental concerns remain however, technically, no resistance remains due to overhead supply. This Chinese Medical/Dental Services firm hit is perched at its 52-week high following 3 consecutive gains. Earnings history is not a match with the fact-based investment system's guidelines, however the Jun '13 quarterly comparison showed an earnings increase of +39%, above the +25% guideline (C criteria) on +9% sales revenues.
5/14/2013 1:23:12 PM - This Chinese Medical/Dental Services firm hit another new 52-week high today while adding to an impressive spurt of volume-driven gains. Several of its gains were marked by above averages volume since finding support at its 50 DMA line. Fundamental concerns remain since noted in the 12/13/12 mid-day report with caution - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
4/30/2013 1:26:42 PM - This Chinese Medical/Dental Services firm is perched at its 52-week high today after an impressive streak of 7 consecutive gains. Several of its gains were marked by above averages volume since finding support at its 50 DMA line. Fundamental concerns remain since noted in the 12/13/12 mid-day report with caution - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
4/29/2013 12:49:23 PM - This Chinese Medical/Dental Services firm hit a new 52-week high with above average volume behind today's 7th consecutive gain. Recently found support at its 50 DMA line. Fundamental concerns remain since noted in the 12/13/12 mid-day report with caution - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
4/24/2013 12:56:46 PM - This Chinese Medical/Dental Services firm has been consolidating above its 50 DMA line. Fundamental concerns remain since last noted in the 12/13/12 mid-day report with cautioned - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
12/13/2012 12:44:05 PM - This Chinese Medical/Dental Services firm has been rebounding after a streak of 5 consecutive losses, on track today for a 5th consecutive gain. There was a negative reversal at its 52-week high as the 11/30/12 mid-day report noted - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
12/6/2012 12:29:59 PM - This Chinese Medical/Dental Services firm is on track today for a 5th consecutive loss since last noted in the 11/30/12 when there was a negative reversal at its 52-week high - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
11/30/2012 12:35:18 PM - This Chinese Medical/Dental Services firm is hitting another new 52-week high today while adding to a spurt of volume-driven gains. Prior mid-day reports repeatedly noted - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
11/23/2012 11:20:37 AM - This Chinese Medical/Dental Services firm is perched near its 52-week high today following a spurt of volume-driven gains. Prior mid-day reports noted - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
11/16/2012 12:46:14 PM - This Chinese Medical/Dental Services firm rallied to another new 52-week high with today's gain. The 11/14/12 mid-day report noted - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
11/14/2012 12:30:00 PM - This Chinese Medical/Dental Services firm rallied to a new 52-week high with today's 4th consecutive gain. It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria).
4/30/2010 2:31:42 PM - This Chinese Medical/Dental Services firm has been holding its ground following a gap up on 4/26/10 on news it is to be acquired by Charles River Labs in a $1.6 billion M&A deal. It had been consolidating since last noted in the 1/08/10 mid-day report without making any headway.
4/29/2010 1:09:27 PM - This Chinese Medical/Dental Services firm has been holding its ground following a gap up on 4/26/10 on news it is to be acquired by Charles River Labs in a $1.6 billion M&A deal. It had been consolidating since last noted in the 1/08/10 mid-day report without making any headway.
4/28/2010 12:44:36 PM - This Chinese Medical/Dental Services firm is holding its ground following a gap up on 4/26/10 on news it is to be acquired by Charles River Labs in a $1.6 billion M&A deal. It had been consolidating since last noted in the 1/08/10 mid-day report without making any headway.
4/27/2010 2:04:49 PM - This Chinese Medical/Dental Services firm is holding its ground following a gap up on 4/26/10 on news it is to be acquired by Charles River Labs in a $1.6 billion M&A deal. It had been consolidating since last noted in the 1/08/10 mid-day report without making any headway.
4/26/2010 1:31:08 PM - This Chinese Medical/Dental Services firm gapped up today on news it is to be acquired by Charles River Labs in a $1.6 billion M&A deal. It had been consolidating since last noted in the 1/08/10 mid-day report without making any headway.
1/8/2010 1:39:32 PM - This Chinese Medical/Dental Services firm gapped up today, challenging its 52-week highs. It has been consolidating in a tight trading range above its 50 DMA line for the past 6 weeks since its considerable gain for a new 2009 high was noted on 11/30/09. Its sales revenues and earnings are below the investment system's guidelines.
12/10/2009 12:51:50 PM - This Chinese Medical/Dental Services firm has been consolidating in a tight trading range since its considerable gain for a new 2009 high was noted on 11/30/09. It is extended from the previously noted flat base above its 50 DMA line. Its sales revenues and earnings are below the investment system's guidelines.
11/30/2009 12:42:03 PM - This Chinese Medical/Dental Services firm's considerable gain today for a new 2009 high has it extended from the previously noted flat base above its 50 DMA line. Its sales revenues and earnings are below the investment system's guidelines.
11/19/2009 12:57:54 PM - This Chinese Medical/Dental Services firm is perched near 2009 highs, extended from the orderly flat base above its 50 DMA line previously noted. Its sales revenues and earnings are below the investment system's guidelines.
11/16/2009 1:48:23 PM - This Chinese Medical/Dental Services firm gapped down today for a loss on heavier volume. It was noted last week when it had quietly risen to new 2009 highs from an orderly flat base above its 50 DMA line. Its sales revenues and earnings are below the investment system's guidelines.
11/12/2009 1:13:20 PM - This Chinese Medical/Dental Services firm has quietly risen to new 2009 highs from an orderly flat base above its 50 DMA line. Its sales revenues and earnings are below the investment system's guidelines.
10/16/2009 12:23:02 PM - This Chinese Medical/Dental Services firm gapped up on 10/15/09 from an orderly flat base above its 50 DMA line. The strong action in foreign issues has been a big factor, but its sales revenues and earnings are below the investment system's guidelines.
10/15/2009 12:52:01 PM - This Chinese Medical/Dental Services firm gapped up today from an orderly flat base above its 50 DMA line. The strong action in foreign issues has been a big factor, but its sales revenues and earnings are below the investment system's guidelines.
10/2/2007 1:38:54 PM - This Chinese Medical/Dental Services firm hit new highs with gains on heavy volume. It is up considerably from its strong IPO (priced at $14) in August. The robust action in foreign issues is playing a big factor.